BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 7614659)

  • 1. International Nonproprietary Names (INN) for pharmaceutical substances.
    Kopp-Kubel S
    Bull World Health Organ; 1995; 73(3):275-9. PubMed ID: 7614659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naming drug substances at the national level: mainly in the United Kingdom and the United States.
    Prescrire Int; 2012 Nov; 21(132):279. PubMed ID: 23210269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How INNs are created. Making drug names safer by contributing to INN selection.
    Prescrire Int; 2015 Jun; 24(161):162-5. PubMed ID: 26436175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common stems: international nonproprietary names (INNs): common INN stems provide key information.
    Prescrire Int; 2007 Oct; 16(91):192. PubMed ID: 17926829
    [No Abstract]   [Full Text] [Related]  

  • 5. Compendial issues: WHO.
    Kopp-Kubel S
    J Parenter Sci Technol; 1992; 46(6):201-5. PubMed ID: 1474431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic drug names and social welfare.
    Lobo F; Feldman R
    J Health Polit Policy Law; 2013 Jun; 38(3):573-97. PubMed ID: 23418366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstacles to the universal application of INNs.
    Prescrire Int; 2014 Oct; 23(153):248-51. PubMed ID: 25964979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of the database on nonproprietary names of drugs].
    Hashiba S; Takenaka Y; Nakadate M
    Eisei Shikenjo Hokoku; 1989; (107):141-5. PubMed ID: 2636918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Safety in Medication Nomenclature: Orthographic and Semantic Properties of International Nonproprietary Names.
    Bryan R; Aronson JK; ten Hacken P; Williams A; Jordan S
    PLoS One; 2015; 10(12):e0145431. PubMed ID: 26701761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The INNs and outs of antibody nonproprietary names.
    Jones TD; Carter PJ; Plückthun A; Vásquez M; Holgate RG; Hötzel I; Popplewell AG; Parren PW; Enzelberger M; Rademaker HJ; Clark MR; Lowe DC; Dahiyat BI; Smith V; Lambert JM; Wu H; Reilly M; Haurum JS; Dübel S; Huston JS; Schirrmann T; Janssen RA; Steegmaier M; Gross JA; Bradbury AR; Burton DR; Dimitrov DS; Chester KA; Glennie MJ; Davies J; Walker A; Martin S; McCafferty J; Baker MP
    MAbs; 2016; 8(1):1-9. PubMed ID: 26716992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. By any other name: ambiguity in marketing proprietary anti-infective agents.
    Berger SA
    Clin Infect Dis; 2007 Jan; 44(1):65-8. PubMed ID: 17143817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International nonproprietary names for monoclonal antibodies: an evolving nomenclature system.
    Guimaraes Koch SS; Thorpe R; Kawasaki N; Lefranc MP; Malan S; Martin ACR; Mignot G; Plückthun A; Rizzi M; Shubat S; Weisser K; Balocco R
    MAbs; 2022; 14(1):2075078. PubMed ID: 35584276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Think INN, prescribe INN, dispense INN: good professional practice.
    Prescrire Int; 2000 Dec; 9(50):184-90. PubMed ID: 11475502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The INN global nomenclature of biological medicines: A continuous challenge.
    Robertson JS; Chui WK; Genazzani AA; Malan SF; López de la Rica Manjavacas A; Mignot G; Thorpe R; Balocco R; Rizzi M
    Biologicals; 2019 Jul; 60():15-23. PubMed ID: 31130314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International nonproprietary names for pharmaceutical substances.
    WHO Chron; 1980 Mar; 34(3 Suppl):1-19. PubMed ID: 7368732
    [No Abstract]   [Full Text] [Related]  

  • 17. International nonproprietary names for pharmaceutical substances.
    WHO Chron; 1971 Mar; 25(3):123-52. PubMed ID: 5551857
    [No Abstract]   [Full Text] [Related]  

  • 18. Physician use of brand versus generic drug names in 1993-1994 and 2003-2004.
    Kwo EC; Kamat P; Steinman MA
    Ann Pharmacother; 2009 Mar; 43(3):459-68. PubMed ID: 19261956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug name recognition and classification in biomedical texts. A case study outlining approaches underpinning automated systems.
    Segura-Bedmar I; Martínez P; Segura-Bedmar M
    Drug Discov Today; 2008 Sep; 13(17-18):816-23. PubMed ID: 18602492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The information potential of the names of drugs].
    Springer V; Kolár J; Chalabala M
    Vnitr Lek; 2004 Feb; 50(2):91-7. PubMed ID: 15077580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.